Asia Pacific Healthcare Outlook 2012-2015: What comes next..
The Healthcare industry is undergoing a rapid transformation with a number of macro trends colliding together such as mobility, internet, consolidation, patient empowerment, global pandemics, aging population, evidence based medicine, prevention, medical tourism, etc. to create business model changes. These trends are altering the way Healthcare is implemented and delivered.
This briefing will focus on the outlook for Asia Pacific with respect to these business model changes in pharmaceuticals, devices, diagnostics and Healthcare Information Technology and highlight growth opportunities for 2012 and beyond.
Pieter will be speaking about his Number 1 Neurosurgical app in the world, "Neuromind", as well as other web developments in the medical field, including his work in the IT department of his hospital, as well as his passion for Medical Infomatics
Cerepro is an app designed for patients with Traumatic Brain Injury, by a patient who, himself, suffered this type of injury. He discusses the purpose of this app to rehabilitlate Traumatic Brain Injury Patients in both their focal motor, and memory skills.
This free webinar will summarise the results of the HFMA’s NHS Financial Temperature Check survey of Finance Directors and Chief Financial Officers in England, published in November 2015. You will hear from Paul Briddock, HFMA Director of Technical and Policy, about the financial outlook for the NHS in England, the views of finance directors from NHS organisations and what the HFMA thinks needs to happen to ensure the NHS can meet the financial challenges ahead
Learn how to deliver integrated health and social care with big data and interoperability.
The Caldicott 2 report highlighted the practical difficulties that surround the sharing of service user data, especially when it’s not being used for direct care. Yet you still need to utilise big data and data sharing to comply with government policies aimed at providing better care.
Join us for this half-day executive briefing where experts from NHS England,Dell Healthcare will provide practical insights on how to enable interoperability and the use of business intelligence to better serve your communities.
We’ll show you how your healthcare data can help gain actionable insights, avoid unseen risks and discover missed opportunities using real-world examples.
Get insights on how to:
•Integrate data from different sources (such as the local authority and NHS commissioners)
•Create healthier communities, improve outcomes and lower healthcare costs through the innovative use of data analysis to predict and prevent ill-health
•Improve the patient engagement experience through seamless
•Ensure a more timely exchange of data to meet regulatory
•Create a cloud-based repository for data that can be accessed
from multiple locations and via different applications
In this webinar, learn about the new capabilities in the Informatica PowerCenter 10 editions and how they will increase your development agility.
Through the eyes and daily routine of typical developers and business analysts you will discover how this new release:
. Enhances the collaboration between IT developers and business analysts
. Delivers more powerful visualization for data profiling
. Delivers a new monitoring dashboard to view service health and system usage
. Increases your productivity with up to 50X faster data lineage rendering
. Enhances your project reach with new connectors and real time capabilities
. Includes new capabilities for parsing semi-structured and unstructured data
Watch this webinar to accelerate your deliver of data integration-based value to your organization.
Are you ready to transform healthcare with predictive analytics? Are you ready to turn Data into Insights and Insights into Practice? Predictive Analytics is about making better healthcare decisions. Is your organization Future Ready?
Frost & Sullivan’s annual forecast aims to help stakeholders understand key issues affecting the healthcare industry. In 2016, advances in areas ranging from wearables to blood testing and artificial intelligence are expected to help shape the industry.
This webinar will help attendees:
• Obtain insightful analyst predictions and probative analysis of the global healthcare industry in 2016
• Discover key strategies and initiatives executed by organizations to capture solutions in health, wellness, and prevention
• Track the progress of key macro-level industry trends and their projected milestones for 2016
• Participate in an interactive Q&A session with Frost & Sullivan’s senior industry thought leaders
Greg Caressi, Frost & Sullivan; Chris Gough, Intel; Dr. David Delaney, SAP; Dr. Kevin Fitzpatrick, CancerLinQ
This session will share insights into how SAP’s HANA in-memory database along with Intel tailored hardware are being leveraged by the American Society of Clinical Oncology, to bring genome aware medicine to cancer patients everywhere.
Policies in ASEAN are directed towards creating a single ASEAN market. It will be achieved through individual national initiatives to increase the competitiveness of their nation, providing a single window to access an estimated 671.6 million consumers with a combined estimated GDP per capita of $6,552 in 2020.
The study of the TOP 6 policies in ASEAN reveals their impact towards healthcare delivery value chain from manufacturer and suppliers to the hospitals and insurers, and where opportunities for growth, diversification and change of business models are expected.
Expected tangible insights:-
•ASEAN Healthcare Market – Size and Projected Growth
•Stages of development and compliances to policies
•Insights and analysis of the following:-
oASEAN Economic Community
oASEAN Medical Device Directive
oUniversal Health Coverage in Indonesia
oOnline-Catalogue and Purchasing
oThailand Medical Hub
oMyanmar Companies Act
•Market Opportunities and Risks
•Game Changing Environments
Shawn Dolley, Cloudera; Chris Gough, Intel and Vijay Venkatesan, Sutter Health
- Hear examples of unstructured data types most commonly added to healthcare Big Data implementations
- From the semantic web to ICU audio files, which are the most interesting data sources inside and outside of the clinic
- The coolest ‘v’ of the four ‘v’s of Big Data is variety; hear best practices on adding this to a data lake
- Predicting readmission and sepsis has proliferated, what’s next?
- Data science is now mainstream and much easier in a Big Data sandbox, what’s the easiest way to set this up in healthcare?
Sowmya Srinath, Research Manager and Tanvir Jaikishen, Senior Research Analyst
It is a known fact that Europe’s Big 5 Health Systems are in transition. The transition is plagued by resource shortages, funding deficiencies, and demand increase from the patient population. The transition can never be a one-size-fits-all solution. Efficiency is not the solution to all of the issues.
This webinar will assess the evolution of these health systems to understand if changes in care provision reflect sound policy making or are a knee-jerk response to changing external factors.
Tod Davis, Children’s Healthcare of Atlanta; Amandeep Khurana, Cloudera and Chris Gough, Intel Health & Life Sciences
Hear perspectives and insights from industry thought leaders regarding:
- Hype vs. reality in real world applications of ‘big data’ systems in healthcare delivery?
- Why now?
- Through case studies some examples of plausible expectations for the scale and timeframe of ROI.
- What changes in operations , infrastructure, and protocol is required to ensure maximum value of invested technologies?
Jane Andrews, Ph.D., senior consultant, Healthcare & Life Science
Cell therapy is the fastest growing segment of regenerative medicine. Cell therapy is comprised of immune cell therapy and stem cell therapy, with stem cell therapy making up the largest part of this market; it is estimated that the global stem cell therapy market will reach $40 billion by 2020 and $180 billion by 2030.
Many factors determine the rate at which the stem cell therapy market advances. It is driven by the success of stem cell treatments in curing life-threatening diseases such as cancer, heart diseases and neuromuscular diseases in the world’s aging populations. In contrast, the stem cell market growth rate is hindered by manufacturing and regulatory concerns. For example, if only 20% of the 318 global late-stage clinical trials are approved for release on the market, there will not be enough stem cell therapy manufacturing facilities to produce the 64 resulting products. This is due, in part, to funding concerns, the high cost of build-out, as well as cGMP compliance, standardization of production processes, and ever changing industry regulations.
Jane Andrews, Ph.D ; Sanjeev Kumar ; Rhenu Bhuller
Cell therapy is the fastest growing segment of regenerative medicine. Cell therapy is comprised of immune cell therapy and stem cell therapy, with stem cell therapy making up the largest part of this market: it is estimated that the global stem cell therapy market will reach $40 billion by 2020 and $180 billion by 2030.
Many factors determine the rate at which the stem cell therapy market advances. It is driven by the success of stem cell treatments in curing life-threatening diseases such as cancer, heart diseases and neuromuscular diseases in the worlds aging populations. In contrast, stem cell market growth rate is hindered by manufacturing and regulatory concerns. For example, if only 20% of the 318 global late stage clinical trials are approved for release on the market, there will not be enough stem cell therapy manufacturing facilities to produce the 64 resulting products. This is due, in part, to funding concerns, the high cost of build-out as well as cGMP compliance, standardization of production processes, and ever changing industry regulations.
The Asia Pacific is the third largest pharmaceutical market in the world after North America and Europe, with generics being the major driver for the pharmaceutical industry in this region, aided by factors such as the aging population and impending expiry of patented drugs. It is a necessity for pharmaceutical companies to be aware of the key trends in the APAC generics market and maximise the market opportunities in order to remain relevant.
In today’s rapidly evolving business landscape, pharmaceutical companies are also starting to realise the importance of the customer experience as a key differentiator. With a gradual shift from product to the customer, the pharmaceutical industry needs to keep up with other industries in terms of providing the perfect digital customer experience. A well-executed digital strategy is essential for today’s pharmaceutical companies to better connect with their clients.
The healthcare industry is entangled in a transitory phase where therapeutics, products and services are sold into traditional care settings that are saturated and exhausted. Yet, the opportunities for new services and care, like ambulatory, mobile, and home care, lack the appropriate level of maturity to provide robust revenue streams.
As a result, Frost & Sullivan’s experts are predicting a year full of big disruptions, transformations and innovations. What’s in store for pharmaceuticals, biotechnology, medical devices, medical imaging, mobile health, healthcare IT, etc.? This briefing will provide an in-depth discussion examining at what degree we can expect the impact to take hold and transpire over the upcoming year.
Attend this webinar to discover:
•Insightful analyst predictions and probative analysis of the global healthcare industry in 2015.
•Key strategies and initiatives executed by companies and organizations to capture opportunities for solutions in health, wellness, and prevention.
•Track the progress of key macro level industry trends and their projected milestones for 2015.
•An interactive Q&A session with Frost & Sullivan’s senior industry thought leaders.
Public and private sector initiatives continue to transform the Healthcare industry in the Asia-Pacific - and their impact is likely to be seen in the coming months. For example, improving access to quality and affordable healthcare is a major goal of governments across the region, and a focus for reform efforts in many countries.
Frost & Sullivan provides in-depth insights on how impending regulations, ethics and compliance reforms, emerging business and service models and industry partnerships will impact healthcare in the region
Join us as we examine key trends for 2015 and beyond and discuss their impact on pharmaceuticals, medical devices, health technology, insurance, healthcare delivery and wellness across Asia-Pacific.
Given increasing healthcare consumerism and demand for round-the-clock healthcare delivery, hospitals and providers must upgrade their healthcare IT infrastructure to accommodate patient and provider needs. This briefing will investigate the changing technology landscape in hospitals globally and will specifically focus on how hospitals in North America and Europe are adopting health information systems (HIS).
Attend this webinar to discover:
·Information technology systems in hospitals
·Drivers and restraints of HIS
·A technology and adoption roadmap of HIS
Daniel Ruppar, Natasha Gulati, and Shruthi Parakkal
Telecommunication companies are increasingly seeking new revenue streams by exploring vertical markets like healthcare. Though traditional telecommunication services have achieved strong penetration in the healthcare industry, more sophisticated solutions are only now starting to generate sustainable returns and have a long way to go in terms of enabling a new-age healthcare system. While the industry presents promising opportunities, few telecommunication service providers have been able to establish successful business models in this space.
Frost & Sullivan will present insights on critical factors that companies overlook while developing their healthcare strategy.
Attend this webinar to discover:
•Key success factors necessary for all telecommunication companies establishing a healthcare presence
•Emerging business models that promise sustainable revenue for leading telecommunication companies in healthcare
Reenita Das, Siddharth Saha, Venkat Rajan, and Natasha Gulati
Attend this webinar to discover:
•Changes to healthcare delivery: hospitals of the future, aging in place, cost of care innovations
•Role of the patient and consumer influence
•Role of emerging regions as a consumer and competitor
•Novel industry business models
•Key disruptive technologies
Frost & Sullivan will provide an outlook for healthcare in 2014 with detailed insights on the regulatory challenges, investment trends, innovation temperature and emerging business models in the Asia-Pacific Healthcare market.
• Discover the issues involved in regulatory and payer acceptance of biosimilars in the US
• Learn how biosimilars are forecast to penetrate the various biopharmaceutical segments and therapeutic areas
• Understand the potential risks and rewards of this market
• Gain insight into the competitive environment and the potential US market leaders
• Identify the factors with the potential to impact the uptake of biosimilars
With the current advancements in 3-D printing technologies for customized fabrication of complex polymer-based objects, there is much focus on adapting the 3-D printing technologies for healthcare applications. This has aroused interests in engineering bioprinting devices that can develop 3-D structures and at the same time accommodate the incorporation of living cells.
- The session will discuss the following:
- The potential of 3-D printing in healthcareD
- Drivers and challenges for the technology
- Impact of 3-D printing, scenario melling
GE sponsored whitepaper research from Frost & Sullivan finds that the most severe obstacle in the daily work of Australian radiologists is data fragmentation and inefficient information management. Lack of interoperability and inadequate communication amongst systems and departments lead to critical time pressures that impact the radiologists’ productivity.
Our Helthcare webcasts cover Connected Health, Life Sciences and Advanced Medical Technologies to help you to better understand buyer-seller dynamics as the healthcare system transitions to digital information, the pace at which new and innovative medical devices and systems are being adopted and getting embedded into the typical clinical pathway, both in mature and emerging markets, and enables you to bring clarity to pharmaceutical/biotechnology, in-vitro diagnostics and life science research tools market decisions and implementation tactics.